These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 343554)

  • 1. Alternatives to aspirin, derived from biological sources.
    Whitehouse MW; Rainsford KD; Ardlie NG; Young IG; Brune K
    Agents Actions Suppl; 1977; (1):43-57. PubMed ID: 343554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation inhibition provoked by eterilate, benorylate and their molecular components, in comparison with acetylsalicylic acid].
    Ortega P; Alonso S; Navarro JL
    Arch Farmacol Toxicol; 1978 Apr; 4(1):150-2. PubMed ID: 29570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the in vitro anti-aggregating action of various salicylic derivatives].
    Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):89-92. PubMed ID: 7325722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of eterylate on "in vitro" Platelet function in human plasma (author's transl)].
    Ortega MP; Priego JG; Sunkel C; Armijo M
    Arch Farmacol Toxicol; 1980 Apr; 6(1):31-40. PubMed ID: 6104474
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies of imidazole 2-hydroxybenzoate (ITF 182), an antiinflammatory compound with an action on thromboxane A2 production.
    Pagella PG; Bellavite O; Agozzino S; Donà GC; Cremonesi P; De Santis F
    Arzneimittelforschung; 1983; 33(5):716-26. PubMed ID: 6603228
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.
    de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of eterilate, benorylate and acetylsalicylic acid on blood glucose in normal and experimentally diabetic rats].
    Alonso S; Ortega MP; Armijo M
    Arch Farmacol Toxicol; 1983 Aug; 9(2):183-90. PubMed ID: 6140900
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benorylate toxicity in animals and renal excretion in man].
    Rohrbach Ph; Laroche MJ; Teche G
    Therapie; 1977; 32(1):89-98. PubMed ID: 17175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of some salicylates associated with other non-steroidal anti-inflammatory drugs on the release of prostacyclin from the gastric mucosa of the rat].
    Cifone MG; Alesse E; Ianni G; Continenza MA; Conti P
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1666-71. PubMed ID: 6762887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural alterations of hepatic microbodies.
    Hruban Z; Swift H; Slesers A
    Lab Invest; 1966 Dec; 15(12):1884-901. PubMed ID: 4289682
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological study of 2-phosphonoxybenzoic acid (fosfosal), a new analgesic drug.
    Rafanell JG; Bellés L; Sánchez MS; Forn J
    Arzneimittelforschung; 1980; 30(7):1091-8. PubMed ID: 6251858
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological properties of eterylate, a new derivative of acetylsalicylic acid.
    Sunkel C; Cillero F; Armijo M; Piña M; Alonso S
    Arzneimittelforschung; 1978; 28(10):1692-4. PubMed ID: 39567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of salicylates on the canine stomach: a morphological and histochemical study.
    Lev R; Siegel HI; Glass GB
    Gastroenterology; 1972 May; 62(5):970-80. PubMed ID: 4537358
    [No Abstract]   [Full Text] [Related]  

  • 15. Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid.
    Higuchi S; Tanaka N; Shioiri Y; Otomo S; Aihara H
    Int J Tissue React; 1986; 8(4):327-31. PubMed ID: 3091522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-inflammatory and analgesic effects of eterilate, benorylate and acetylsalicylic acid].
    Piña M; Armijo M
    Arch Farmacol Toxicol; 1978 Apr; 4(1):183-6. PubMed ID: 29572
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.
    Simrock R; Missalla A; Schwidtal P; Lischke V; Breddin HK
    Thromb Haemost; 1984 Apr; 51(2):269-71. PubMed ID: 6740559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of salicylates on the toxicity of GABAlytics for mice].
    Golovko AI; Sofronov GA; Kliuntina TV
    Biull Eksp Biol Med; 1995 Jun; 119(6):619-20. PubMed ID: 8589387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of acute and chronic toxicity of etherilate, benorylate and acetylsalicylic acid].
    Alonso S; Priego J; Maroto L; Ortega P
    Arch Farmacol Toxicol; 1978 Apr; 4(1):167-9. PubMed ID: 29571
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.